All In Biotech

Drug Trial Radar · NCT07128628

A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease

Last checked: Nov 20, 2026Latest source record: Jul 14, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 443 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

443

Actual

Start

Oct 24, 2025

Primary completion

May 28, 2026

Study completion May 28, 2026

Sponsor

Lead sponsor
Bausch & Lomb IncorporatedIndustry
Sponsor type
Industry
First posted
Aug 19, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Multicenter Study Evaluating Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination Administered Twice Daily on Signs and Symptoms of Dry Eye Disease

Conditions

  • Dry Eye Disease

Interventions

  • Lifitegrast/Perfluorohexyloctane Fixed Dose CombinationDrug

    Topical ocular drop of lifitegrast and perfluorohexyloctane administered for 4 weeks

  • LifitegrastDrug

    Topical ocular drop of lifitegrast administered for 4 weeks

  • PerfluorohexyloctaneDrug

    Topical ocular drop of perfluorohexyloctane administered for 4 weeks

  • VehicleDrug

    Topical ocular drop with no active ingredients administered for 4 weeks

  • VehicleDrug

    Topical ocular drop with no active ingredients administered for 4 weeks

  • VehicleDrug

    Topical ocular drop with no active ingredients administered for 4 weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total corneal fluorescein staining change from baselineTime frame: Baseline, day 29

Locations

32 sites in 1 country. Site status is shown where the registry gives one.

  • Eye Doctors of Arizona, PLLC

    Phoenix, Arizona

  • Global Research Management, Inc.

    Glendale, California

  • SoCal Eye - Lakewood Clinic

    Long Beach, California

  • LoBue Laser and Eye Medical Center

    Murrieta, California

  • Eye Research Foundation, Inc.

    Newport Beach, California

  • Wolstan and Goldberg Eye Associates

    Torrance, California

  • Segal Drug Trials/Office of Bruce A Segal, MD

    Delray Beach, Florida

  • Bowden Eye and Associates

    Jacksonville, Florida

  • Shettle Eye Research, Inc

    Largo, Florida

  • Clayton Eye Clinical Research, LLC

    Morrow, Georgia

  • Midwest Cornea Associates LLC

    Carmel, Indiana

  • Kannarr Eye Care, LLC

    Pittsburg, Kansas

  • Vance Thompson Vision - Alexandria

    Alexandria, Minnesota

  • Complete Eye Care of Medina

    Medina, Minnesota

  • Insight Eyecare Specialties, Inc.

    Kansas City, Missouri

  • Moyes Eye Center, P.C.

    Kansas City, Missouri

  • Ophthalmology Consultants, Ltd.

    St Louis, Missouri

  • Comprehensive Eye Care Ltd.

    Washington, Missouri

  • Opthalmic consultants of Long Island

    Garden City, New York

  • Rochester Ophthalmological Group,PC

    Rochester, New York

  • Asheville Eye Associates

    Asheville, North Carolina

  • Oculus Research

    Garner, North Carolina

  • CORE Inc.

    Shelby, North Carolina

  • Vance Thompson Vision - Fargo, ND

    West Fargo, North Dakota

  • Insight Research Clinic LLC.

    Powell, Ohio

  • Scott & Christie Eyecare Associates - The Surgery Center at Cranberry

    Cranberry Township, Pennsylvania

  • West Bay Eye Associates

    Warwick, Rhode Island

  • Southern College of Optometry

    Memphis, Tennessee

  • Total Eye Care PA

    Memphis, Tennessee

  • Advancing Vision Research, LLC

    Smyrna, Tennessee

  • Intouch Clinical Research Center

    Houston, Texas

  • Lake Travis Eye and Laser Center

    Lakeway, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.